• Vt. to get $1.1 million drug settlement
    November 17,2012
    • Email Article
    •  
    •  Print Article
     
    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.
    • Email Article
    •  
    •  Print Article
    2 Comments
    MORE IN Vermont News
    SUNDERLAND — Holding a sandwich bag containing a squirming, Eastern red-spotted newt, Evan Grant... Full Story
    Saving salamanders: Searching for signs of a deadly fungus
    The Vermont Agency of Transportation has decided to yank a new seat belt safety ad from the... Full Story
    State pulls seat belt safety ad
    “Vermont is still at the bottom of the barrel when it comes to state support for higher education. Full Story
    More Articles